MAJIN Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

MAJIN (membrane-anchored junction protein) is part of the ternary MAJIN-TERB2-TERB1 (TTM) complex, which tethers meiotic telomeres to the NE. This interaction facilitates chromosomal synapsis and homologous recombination. MAJIN antibodies enable researchers to:

  • Localize MAJIN within cellular compartments.

  • Investigate its binding partners (TERB1/TERB2).

  • Disrupt TTM complex interactions to study functional consequences .

Molecular Architecture

The MAJIN-TERB2 hetero-tetramer forms a structural core that binds DNA and links telomeres to the NE via transmembrane domains. Key features:

  • MAJIN N-terminal domain (NTD): Binds TERB2 via a hydrophobic interface (residues 168–202 of TERB2) .

  • DNA-binding region: A basic patch on MAJIN’s surface mediates electrostatic interactions with DNA .

Table 1: MAJIN-TERB2 Interaction Mutants

Mutation (TERB2)Interaction DisruptedExperimental Outcome
Y56ETERB1-TERB2Loss of TERB1 binding
F192RMAJIN-TERB2Loss of MAJIN binding

Functional Consequences

Disrupting MAJIN-TERB2 binding (e.g., via F192R mutation) in mice leads to:

  • Failed telomere-NE attachment.

  • Meiotic arrest and infertility .

  • Defective synapsis and DNA repair .

Immunoprecipitation (Co-IP) Studies

MAJIN antibodies validate protein-protein interactions. For example:

  • Y56E mutation: Abolishes TERB1-TERB2 binding, confirmed via Co-IP .

  • F192R mutation: Eliminates MAJIN-TERB2 interaction, preventing NE tethering .

Localization and Imaging

  • Nuclear membrane localization: MAJIN antibodies detect MAJIN’s enrichment at the NE in U-2 OS cells .

  • Pathological models: Used to study telomere detachment in meiotic disorders.

Antibody Development and Validation

While no commercial MAJIN antibodies are explicitly cited, methodologies from analogous studies include:

  • Hybridoma screening: Clones are screened via ELISA and immunohistochemistry (IHC) to ensure specificity .

  • Recombinant antibodies: Engineered for higher stability and lower immunogenicity .

Table 2: Key MAJIN Antibody Characteristics

ApplicationTarget EpitopeValidation MethodSource
Co-IPMAJIN NTD (1–112)Crystal structureLewis et al.
IHCMAJIN C-terminalKO cell line controlsYCharOS

Therapeutic Potential and Challenges

  • Infertility treatments: Targeting meiotic defects caused by MAJIN dysfunction.

  • Cancer research: Aberrant telomere dynamics are linked to genomic instability .

Future Directions

  • High-resolution imaging: Cryo-EM studies of MAJIN-antibody complexes.

  • Gene-editing models: CRISPR-Cas9 to explore MAJIN’s role in non-meiotic cells.

MAJIN antibodies remain pivotal in dissecting the molecular choreography of meiosis. Their application bridges structural biology and reproductive health, offering avenues to address infertility and chromosomal disorders.

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we are able to ship your order within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. Please consult your local distributor for specific delivery time estimates.
Synonyms
MAJIN antibody; C11orf85Membrane-anchored junction protein antibody
Target Names
MAJIN
Uniprot No.

Target Background

Function
MAJIN is a meiosis-specific telomere-associated protein that plays a critical role in the attachment of meiotic telomeres to the inner nuclear membrane. This attachment is essential for homologous pairing and synapsis during meiosis. MAJIN is part of the MAJIN-TERB1-TERB2 complex, which facilitates telomere cap exchange by mediating the binding of telomeric DNA to the inner nuclear membrane and replacing the protective cap of telomeric chromosomes. During early meiosis, the MAJIN-TERB1-TERB2 complex associates with both telomeric DNA and the shelterin/telosome complex. As prophase progresses, the complex matures and promotes the release of the shelterin/telosome complex from telomeric DNA. Within the complex, MAJIN serves as the anchoring subunit to the inner nuclear membrane. MAJIN exhibits DNA-binding activity, which may contribute to the stabilization of telomere attachment to the inner nuclear membrane.
Database Links

HGNC: 27441

OMIM: 617130

KEGG: hsa:283129

UniGene: Hs.567793

Protein Families
MAJIN family
Subcellular Location
Nucleus inner membrane; Single-pass membrane protein. Chromosome, telomere.

Q&A

What is the MAJIN protein and why is it significant in research?

MAJIN (Membrane-Anchored Junction Protein) is a critical structural protein encoded by the MAJIN gene (Gene ID: 283129). It functions as a component of the telomere attachment complex, essential for meiotic cell division processes. This protein is significant in research related to:

  • Reproductive biology and infertility investigations

  • Meiotic recombination and chromosome pairing studies

  • Telomere biology and genomic stability research

  • Spermatogenesis and oogenesis developmental pathways

The protein's role in creating stable attachments between chromosomes and the nuclear envelope during meiosis makes it a valuable target for studying reproductive disorders and fundamental cellular mechanisms .

What detection methods are compatible with MAJIN antibodies?

Based on available product specifications, MAJIN antibodies have been validated primarily for Western Blot applications. The recommended dilution range for Western Blot applications is typically 1:500-2000, but optimal concentrations should be determined experimentally for specific sample types .

While Western Blot represents the primary validated application, researchers may explore additional techniques with appropriate validation:

  • Immunohistochemistry (tissue sections)

  • Immunocytochemistry (cellular preparations)

  • Immunoprecipitation studies

  • Flow cytometry (with appropriate permeabilization)

When adapting MAJIN antibodies to non-validated applications, extensive controls and optimization steps are essential to ensure specificity and proper interpretation of results.

How should MAJIN antibodies be stored and handled for optimal performance?

For maximum stability and activity retention:

  • Store at -20°C for up to 1 year from receipt date

  • Avoid repeated freeze-thaw cycles by preparing working aliquots

  • Typical formulation includes PBS, 50% Glycerol, 0.5% BSA, and 0.02% Sodium Azide

  • Allow antibody to equilibrate to room temperature before opening

  • Centrifuge vial briefly before use to collect solution at the bottom

  • Return to appropriate storage immediately after use

Working dilutions should be prepared fresh whenever possible, particularly for sensitive applications .

What controls are essential when using MAJIN antibodies in experimental workflows?

Proper experimental design with MAJIN antibodies should include:

Positive Controls:

  • Known MAJIN-expressing tissues/cells (e.g., testicular tissue for reproductive studies)

  • Recombinant MAJIN protein standards

  • Cell lines with verified MAJIN expression (e.g., A431 cells as demonstrated in validation data)

Negative Controls:

  • Samples from knockout models (when available)

  • Non-specific IgG from same species as primary antibody

  • Samples known to lack MAJIN expression

  • Primary antibody omission controls

Additional Validation:

  • Peptide competition assays using immunogen peptide

  • Secondary antibody-only controls

  • Gradient of protein loading to establish detection limits

How can specificity of MAJIN antibody be validated in research applications?

Comprehensive validation strategies include:

  • Western Blot Analysis:

    • Confirm single band of expected molecular weight

    • Compare against characterized cell lines (e.g., A431 cells)

    • Test multiple tissues to confirm expected expression pattern

  • Peptide Competition:

    • Pre-incubate antibody with excess immunizing peptide

    • Signal should be significantly reduced if antibody is specific

  • Genetic Approaches:

    • Compare wild-type to knockout/knockdown samples

    • Overexpression systems should show enhanced signal

  • Cross-species Reactivity:

    • Test across human, mouse, and rat samples to confirm expected conservation pattern

    • Document any species-specific variations in molecular weight or detection sensitivity

What are the optimal Western Blot conditions for MAJIN antibody detection?

For reliable and reproducible Western Blot results with MAJIN antibodies:

Protocol Optimization Table:

ParameterRecommended ConditionsNotes
Sample PreparationAdd protease inhibitors, maintain cold chainMAJIN protein may be susceptible to degradation
Protein Loading20-40 μg total proteinAdjust based on expression level in sample
Gel Percentage10-12% SDS-PAGEAppropriate for MAJIN's molecular weight
Transfer MethodWet transfer, 30V overnight at 4°CEnsures efficient transfer of protein
Blocking Solution5% non-fat milk or BSA in TBSTTest both to determine optimal background reduction
Primary Antibody1:1000 dilution, 4°C overnightOptimize based on specific lot and sample type
Secondary Antibody1:5000 dilution, 1 hour at RTHRP-conjugated anti-rabbit IgG
Washing4 × 5 min in TBSTThorough washing reduces background
DetectionEnhanced chemiluminescenceAdjust exposure time based on signal strength

While published protocols provide starting points, researchers should validate these conditions for their specific experimental system .

How do polyclonal MAJIN antibodies compare with monoclonal options in research applications?

When selecting between polyclonal and monoclonal MAJIN antibodies, consider:

Polyclonal Advantages:

  • Recognize multiple epitopes, enhancing detection sensitivity

  • Often more robust to minor protein denaturation or modification

  • Currently more widely available for MAJIN detection

  • May perform better across species due to recognition of conserved epitopes

Polyclonal Limitations:

  • Batch-to-batch variability requires validation of new lots

  • Higher potential for cross-reactivity with structurally similar proteins

  • Less suitable for highly specific epitope targeting

Monoclonal Considerations:

  • Offer exceptional specificity for defined epitopes

  • Provide consistent reproducibility across experiments

  • May have reduced sensitivity compared to polyclonal options

  • Limited epitope recognition can be problematic if target region is masked

Current research predominantly uses affinity-purified polyclonal antibodies raised against synthetic peptides derived from human MAJIN .

What are potential cross-reactivity concerns with MAJIN antibodies and how can they be mitigated?

Cross-reactivity remains a significant concern in antibody-based research. For MAJIN antibodies:

  • Potential Cross-Reactivity Sources:

    • Structurally similar membrane junction proteins

    • Other telomere-associated proteins with similar domains

    • Non-specific binding to hydrophobic regions

  • Mitigation Strategies:

    • Extensive pre-adsorption against tissue lysates

    • Validation across multiple techniques (Western blot plus orthogonal methods)

    • Parallel experiments with antibodies targeting different MAJIN epitopes

    • Genetic validation through knockdown/knockout approaches

  • Analytical Approaches:

    • Perform mass spectrometry on immunoprecipitated samples

    • Compare reactivity patterns across tissues with known MAJIN expression profiles

    • Use dilution studies to establish specific signal-to-noise thresholds (similar to approaches used for other antibodies)

How can MAJIN antibodies be integrated into studies of reproductive disorders?

MAJIN antibodies can provide valuable insights in reproductive research:

  • Meiotic Progression Analysis:

    • Immunolocalization of MAJIN in testicular or ovarian tissues

    • Correlation with meiotic stage markers

    • Quantification of MAJIN localization defects in infertility models

  • Telomere Attachment Complex Dysfunction:

    • Western blot quantification of MAJIN levels in patient samples

    • Co-immunoprecipitation with other complex components (TERB1, TERB2)

    • Correlation of expression levels with clinical parameters

  • Experimental Approaches:

    • Immunofluorescence microscopy to visualize telomere-nuclear envelope attachments

    • Chromatin immunoprecipitation to assess telomere association

    • Protein complex interaction studies combined with functional assays

Research design should incorporate appropriate tissue and cellular controls with proper validation of antibody specificity in reproductive tissues.

What considerations are important when interpreting MAJIN antibody signal intensity in Western blots?

When analyzing Western blot data from MAJIN antibody experiments:

  • Signal Interpretation Factors:

    • Establish linear detection range through standard curve analysis

    • Account for MAJIN's relatively low abundance in many tissues

    • Consider post-translational modifications that may affect migration pattern

    • Evaluate background signal in negative control samples

  • Quantification Approaches:

    • Normalize MAJIN signal to appropriate loading controls

    • Use technical replicates to establish measurement variability

    • Consider multiple exposure times to ensure signals fall within linear range

    • Compare relative rather than absolute values across experimental conditions

  • Common Analysis Pitfalls:

    • Misinterpretation of non-specific bands

    • Over-reliance on single antibody without validation

    • Failure to account for tissue-specific expression patterns

    • Inadequate normalization for cross-sample comparisons

How might new antibody development technologies improve MAJIN antibody specificity and utility?

Recent advances in antibody technology could enhance MAJIN research:

  • Recombinant Antibody Approaches:

    • Phage display selection against specific MAJIN domains

    • Single B-cell cloning from immunized animals

    • Structure-guided antibody engineering targeting unique epitopes

  • Microfluidic Screening Techniques:

    • High-throughput screening of antibody-secreting cells

    • Isolation of high-affinity binders through droplet-based approaches

    • Rapid identification of functional neutralizing antibodies

  • Computational Optimization:

    • Language model-based antibody sequence optimization

    • Reduction of germline bias to enhance specificity

    • Prediction of key mutations to improve binding properties

These technologies could address current limitations in MAJIN antibody research by providing higher specificity reagents with reduced batch-to-batch variability.

What novel research applications might emerge for MAJIN antibodies beyond current uses?

Potential future research directions include:

  • Therapeutic Applications:

    • Investigation of MAJIN dysfunction in reproductive disorders

    • Development of diagnostic markers for specific meiotic defects

    • Targeted manipulation of telomere attachment mechanisms

  • Developmental Biology:

    • Tracking MAJIN expression during gamete formation

    • Correlation with chromosomal stability markers

    • Integration with single-cell approaches to study meiotic progression

  • Comparative Biology:

    • Analysis of MAJIN conservation and divergence across species

    • Correlation of structural differences with reproductive strategies

    • Evolutionary studies of telomere attachment mechanisms

  • Integration with Advanced Imaging:

    • Super-resolution microscopy of MAJIN localization

    • Live-cell imaging using fluorescently-tagged antibody fragments

    • Correlative light and electron microscopy approaches

As our understanding of MAJIN's biological functions expands, so too will the applications of antibodies targeting this protein in diverse research contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.